Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 October 2020 | Story Leonie Bolleurs | Photo Supplied
Dr Cornel Bender
Dr Cornel Bender received her PhD qualification at the virtual graduation ceremonies in October. The title of her thesis is: Stem rust resistance in South African wheat and triticale.

The rapid distribution of disease-causing organisms such as Ug99, a wheat stem-rust pathotype, pointed out just how vulnerable global cereal production is to disease outbreaks.

These cereals include wheat, barley, rye, oats, triticale, rice, maize, and millet and are one of the most important food sources for human consumption.

According to Dr Cornel Bender, the projected world population of 10 billion in 2057 requires a growth of more than 40% in cereal production. Wheat is grown on more hectares than any other cereal and is one of the most important sources of calories for humans. However, the growth rate of wheat yields has declined from the 1960s to the 1990s. Therefore, it is essential to increase global wheat production.

“With the regular appearance of more aggressive stem rust pathotypes in South Africa, there is a constant need to discover new sources of resistance, understand the genetic base of presently deployed sources in wheat, triticale and barley cultivars, and to manipulate the deployment of resistant sources through a more sustainable approach,” says Dr Bender.

Her PhD thesis, titled: Stem rust resistance in South African wheat and triticale, includes various fundamental aspects for the effective management of stem rust in South Africa.

Dr Bender is a Professional Officer in the Division of Plant Pathology in the Department of Plant Sciences, who received her PhD at the virtual graduation ceremonies in October.

Innovative and cost effective

Her promotors, Prof Zakkie Pretorius, Research Fellow, and Dr Willem Boshoff, Senior Lecturer in the Department of Plant Sciences, believe that she used an innovative approach to develop a cost-effective phenotyping method to select for more durable resistance types in a controlled greenhouse environment.

“In the past, results obtained from field trials used to assess adult plants for stem-rust resistance, were often influenced by abiotic factors, were seasonable in nature, expensive, and time consuming; therefore, the development of a dependable greenhouse screening system provides an important additional instrument for rust research,” says Dr Bender.

She adds that the greenhouse technique is used worldwide to screen for adult plant resistance and contribute to save time and money.

Broadening our knowledge

“Inheritance studies were undertaken to determine the genetic base of stem-rust resistance in selected South African wheat and triticale cultivars (developed from wheat/rye crosses) through seedling analysis as well as greenhouse and fieldwork,” she says.

Dr Bender believes the use and development of different resistance screening methods, the elucidation of host genetics, as well as the use of histological and microscopic methods to study early resistance responses, broaden our knowledge and understanding of stem-rust resistance in South African wheat and triticale cultivars.

Ultimately, rust researchers, grain producers, and also the general public – through access to their daily bread – will benefit from her study.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept